摘要
近年来，分子病理学已经取得了巨大进步。我们对膀胱移行细胞癌（TCC）发生发展以及和生物学行为相关的分子改变作一综述，以阐明其主要的分子机制及临床意义。
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2011年第11期779-782,共4页
Chinese Journal of Pathology
参考文献22
-
1Cheng L, Davidson DD, Maclennan GT, et al. The origins of urothelial carcinoma. Expert Rev Anticancer Ther, 2010, 10 (6) : 865 -880.
-
2Cheng L, Zhang S, MacLennan GT, et 'al. Bladder cancer: translating molecular genetic insights into clinical practice. Hum Patho1,2010,42 (4) :455-481.
-
3Chen M, Kamat AM, Huang M, et al. High+order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis,2007,28(10) :2160-2165.
-
4Chan KS, Espinosa I, Chao M, et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A, 2009,106(33 ) :14016-14021.
-
5van Rhijn BW, Montironi R, Zwarthoff EC, et al. Frequent FGFR3 mutations in urothelial papilloma. J Pathol, 2002, I98 (2) :245-251.
-
6van Rhijn BW, Lurkin I, Radvanyi F, et al. The fibroblast growth factor receptor 3 ( FGFR3 ) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res, 2001,61 (4) :1265-1268.
-
7Tomlinson DC, Baldo O, Harnden P, et al. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J Patho1,2007,213 (1) :91-98.
-
8Bernard-Pien'ot I, Brains A, Dunois-Lard C, et al. Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b. Carcinogenesis, 2006,27(4) :740-747.
-
9Bakkar AA, Wallerand H, Radvanyi F, et aS. FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Res, 2003,63 (23) : 8108- 8112.
-
10Shariat SF, Ashfaq R, Sagalowsky AI, et al. Predictive value of cell cycle biomarkers in nonmusele invasive bladder transitional cell carcinoma. J Uro, 2007,177(2) :d81 487.
同被引文献4
-
1ZHAO J X,YANG L P,WANG Y F,et al.Gelatinolytic actvtity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat biain after implantation of 9Lrat glioma cells[J].Eur j neurol,2007,14(5):510-516.
-
2CHAO H H,LIU J C,HONG H J,et al.L-carnitine reduces doxorubiecin-induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytes[J].Int j cardiol,2011,146(2):14-15.
-
3HORI M,NISHIDS K.Oxidative stress and left ventricular remodeling after myocardial infarction[J].Cardivoasc res,2009,81(3):457-464.
-
4任虎,任明华,倪少滨.膀胱癌早期诊断方法的进展[J].中华临床医师杂志（电子版）,2012,6(14):4029-4031. 被引量：8
-
1许良中.恶性淋巴瘤分子病理学研究进展[J].中国癌症杂志,1997,7(1):64-67. 被引量：1
-
2徐秉栋.原发性肝细胞癌的分子病理学研究进展[J].中华病理学杂志,1991,20(2):150-152. 被引量：2
-
3苏敏,黄天华.实体瘤染色体分子病理学及新技术[J].癌变．畸变．突变,1999,11(6):282-284.
-
4徐选福,王兴鹏.胰腺癌诊断学新认识[J].世界华人消化杂志,2000,8(9):1034-1036. 被引量：6
-
5钱屹崟(综述),倪润洲(审校).胃癌分子病理学及其相关标志物的研究进展[J].肿瘤研究与临床,2012,24(10):716-718.
-
6丛文铭.肝细胞癌克隆起源的分子病理学研究进展[J].中华病理学杂志,1995,24(2):116-119. 被引量：13
-
7Ashley Grossman.垂体肿瘤的分子病理学以及临床治疗[J].中华医学信息导报,2006,21(17):7-8.
-
8王晓杰,林晶,陈誉,师怡,杨眉,陈玲,余家密,郭增清.PTNE蛋白表达对西妥昔单抗联合化疗治疗晚期结直肠癌的影响[J].徐州医学院学报,2015,35(10):667-672. 被引量：1
-
9梅同华.肺癌的靶向治疗进展[J].现代医药卫生,2005,21(5):505-505. 被引量：1
-
10王天宇,肖雄,康鹏,李德岭,张扬,张力伟,季楠.继发胶质母细胞瘤的分子病理学及表观遗传学特征[J].中华神经外科杂志,2015,31(12):1293-1296. 被引量：1
